| ISIN | LU2041625810 |
|---|---|
| Valor Number | 49473283 |
| Bloomberg Global ID | |
| Fund Name | JSS Sustainable Equity - Future Health C EUR acc |
| Fund Provider |
J. Safra Sarasin Investmentfonds AG
Basel, Switzerland Phone: +41 58 317 44 44 Web: www.jsafrasarasin.com |
| Fund Provider | J. Safra Sarasin Investmentfonds AG |
| Representative in Switzerland |
J. Safra Sarasin Investmentfonds AG Basel Phone: +41 58 317 44 00 |
| Distributor(s) |
Bank J. Safra Sarasin AG Basel Phone: +41 58 317 44 00 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | The investment objective of the fund is to achieve long-term capital growth. The Reference Currency of the Sub-Fund is the US Dollar (USD). The assets of the fund are mainly invested worldwide either directly (min. 67% of the SubFund’s assets) or indirectly in equity securities that offer an exposure to one or multiple emerging and transformational health trends. The Sub-Fund invests in leading companies and niche players whose products and services contribute to the improvement of health outcome and the dampening of rising healthcare costs. |
| Peculiarities |
| Current Price * | 113.89 EUR | 01.12.2025 |
|---|---|---|
| Previous Price * | 115.35 EUR | 28.11.2025 |
| 52 Week High * | 115.80 EUR | 25.11.2025 |
| 52 Week Low * | 94.05 EUR | 10.04.2025 |
| NAV * | 113.89 EUR | 01.12.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 146,740,319 | |
| Unit/Share Assets *** | 6,343,377 | |
| Trading Information SIX | ||
| YTD Performance | +5.69% |
31.12.2024 - 01.12.2025
31.12.2024 01.12.2025 |
|---|---|---|
| YTD Performance (in CHF) | +4.98% |
31.12.2024 - 01.12.2025
31.12.2024 01.12.2025 |
| 1 month | +6.05% |
03.11.2025 - 01.12.2025
03.11.2025 01.12.2025 |
| 3 months | +12.14% |
02.09.2025 - 01.12.2025
02.09.2025 01.12.2025 |
| 6 months | +16.17% |
02.06.2025 - 01.12.2025
02.06.2025 01.12.2025 |
| 1 year | +1.93% |
02.12.2024 - 01.12.2025
02.12.2024 01.12.2025 |
| 2 years | +16.16% |
01.12.2023 - 01.12.2025
01.12.2023 01.12.2025 |
| 3 years | -2.11% |
01.12.2022 - 01.12.2025
01.12.2022 01.12.2025 |
| 5 years | +9.02% |
01.12.2020 - 01.12.2025
01.12.2020 01.12.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Johnson & Johnson | 9.13% | |
|---|---|---|
| Eli Lilly and Co | 7.40% | |
| Sanofi SA | 6.91% | |
| argenx SE | 5.42% | |
| Danaher Corp | 4.91% | |
| UnitedHealth Group Inc | 4.86% | |
| Intuitive Surgical Inc | 4.64% | |
| Boston Scientific Corp | 4.53% | |
| Lonza Group Ltd | 4.49% | |
| Fresenius SE & Co KGaA | 3.93% | |
| Last data update | 31.10.2025 | |
| TER | 1.38% |
|---|---|
| TER date | 30.04.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 1.50% |
| Ongoing Charges *** | 1.38% |
|
SRRI ***
|
|
| SRRI date *** | 30.11.2025 |